Bristol Myers Squibb (BMY) 재무상태표
NYSE · Healthcare · Drug Manufacturers - General · 직원 32,500명 · CEO Christopher Boerner
- 주가
- $62.48 +1.78%
- 시가총액
- $1280억
- 기업가치
- $1630억
- 최근 실적
- Q3 '26 2026-10-29 제출
- 다음 실적
- 2027-02-04 EPS 추정 $1.52
Bristol Myers Squibb (BMY)의 Q3 '26말 현금 및 단기투자는 $126억, 리스 포함 차입금은 $448억입니다. 자산총계 $888억, 부채총계 $654억, 주주지분 $234억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $115억 | $93.3억 | $62.9억 | $78.9억 | $103억 | $109억 | $126억 | $157억 | $102억 | $95.7억 | $87.2억 | $95.7억 | |
| 단기투자 | $8.16억 | $3.4억 | $3.6억 | $2.04억 | $5.13억 | $9.07억 | $10억 | $7.76억 | $4.64억 | $9.12억 | $23.5억 | $30.1억 | |
| 매출채권 | $153억 | $141억 | $151억 | $149억 | $144억 | $146억 | $151억 | $146억 | $145억 | $121억 | $106억 | $106억 | |
| 재고자산 | $26.6억 | $29.9억 | $30.8억 | $33.3억 | $25.6억 | $26.7억 | $27.4억 | $27.6억 | $26.9억 | $27.6억 | $27.4억 | $27억 | |
| 기타 유동자산 | $15.6억 | $19.5억 | $20.1억 | $17.5억 | $19.4억 | $17.5억 | $17.8억 | $17.5억 | $15억 | $18.8억 | $42.2억 | $38.4억 | |
| 유동자산 | $318억 | $287억 | $269억 | $281억 | $298억 | $308억 | $332억 | $356억 | $294억 | $272억 | $286억 | $298억 | |
| 유형자산(순액) | $80.4억 | $81.9억 | $81.6억 | $82.5억 | $83.6억 | $84.3억 | $86.5억 | $73.5억 | $91.3억 | $91.9억 | $77.9억 | $79.7억 | |
| 장기투자 | $25억 | $28.9억 | $30억 | $28.5억 | $25.1억 | $22.5억 | $22.5억 | $23.6억 | $25.1억 | $22.4억 | $3.97억 | $3.78억 | |
| 영업권 | $212억 | $217억 | $217억 | $218억 | $217억 | $217억 | $218억 | $217억 | $218억 | $217억 | $217억 | $217억 | |
| 무형자산 | $275억 | $332억 | $298억 | $273억 | $236억 | $228억 | $217억 | $205억 | $194억 | $185억 | $174억 | $169억 | |
| 이연법인세자산 | $27.7억 | $27.2억 | $33.2억 | $36.1억 | $42.4억 | $40억 | $46.5억 | $49.6억 | $53.8억 | $51.8억 | $53.6억 | $58.8억 | |
| 기타 비유동자산 | $14.3억 | $16.6억 | $17억 | $18억 | $23.6억 | $24.3억 | $24.7억 | $43.8억 | $25.3억 | $24.3억 | $63.8억 | $61억 | |
| 비유동자산 | $634억 | $704억 | $678억 | $656억 | $628억 | $616억 | $615억 | $613억 | $606억 | $593억 | $591억 | $590억 | |
| 자산총계 | $952억 | $990억 | $946억 | $937억 | $926억 | $924억 | $947억 | $969억 | $900억 | $865억 | $876억 | $888억 | |
| 부채 | |||||||||||||
| 매입채무 | $32.6억 | $35.4억 | $37.5억 | $34.7억 | $36억 | $40억 | $54.3억 | $42.9억 | $35.8억 | $42.3억 | $41.6억 | $46.3억 | |
| 미지급비용 | $3.49억 | $5.46억 | $5.91억 | $5.12억 | $5.72억 | $5.16억 | $5.75억 | $5.12억 | $4.84억 | $5.07억 | $0 | $0 | |
| 단기차입금 | $31.2억 | $61.9억 | $35.3억 | $10.8억 | $20.5억 | $35.5억 | $47.2억 | $45.1억 | $22.6억 | $23.1억 | $10.3억 | $12.5억 | |
| 미지급세금 | $13.7억 | $14.9억 | $14.7억 | $14.9억 | $15.1억 | $14.5억 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 기타 유동부채 | $128억 | $127억 | $125억 | $147억 | $146억 | $131억 | $144억 | $163억 | $146억 | $97.2억 | $135억 | $129억 | |
| 유동부채 | $223억 | $258억 | $233억 | $226억 | $238억 | $241억 | $275억 | $281억 | $234억 | $192억 | $187억 | $188억 | |
| 장기차입금 | $367억 | $495억 | $489억 | $487억 | $476억 | $462억 | $445억 | $445억 | $429억 | $422억 | $421억 | $418억 | |
| 리스부채(비유동) | $15.3억 | $15.6억 | $14.4억 | $14.8억 | $13.7억 | $13.6억 | $15.5억 | $18.5억 | $18.3억 | $17.7억 | $0 | $17.1억 | |
| 이연수익(비유동) | $3억 | $2.82억 | $2.63억 | $2.47억 | $2.3억 | $2.13억 | $1.97억 | $1.8억 | $1.69억 | $1.55억 | $0 | $1.28억 | |
| 이연법인세부채 | $3.38억 | $4.42억 | $4.61억 | $4.3억 | $3.69억 | $2.76억 | $2.47억 | $2.25억 | $2.22억 | $2.11억 | $2.22억 | $2.28억 | |
| 기타 비유동부채 | $45.9억 | $48.9억 | $32.9억 | $30억 | $28.7억 | $29.1억 | $32억 | $34.3억 | $30.5억 | $29.3억 | $43.4억 | $27억 | |
| 비유동부채 | $434억 | $567억 | $543억 | $538억 | $524억 | $509억 | $497억 | $502억 | $481억 | $472억 | $467억 | $466억 | |
| 부채총계 | $657억 | $825억 | $776억 | $765억 | $762억 | $750억 | $772억 | $783억 | $715억 | $664억 | $653억 | $654억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | |
| 이익잉여금 | $288억 | $156억 | $161억 | $161억 | $149억 | $161억 | $162억 | $171억 | $169억 | $183억 | $203억 | $212억 | |
| 기타포괄손익누계액 | -$15.5억 | -$14억 | -$14.6억 | -$14.7억 | -$12.4억 | -$14.2억 | -$15.5억 | -$15.1억 | -$15.2억 | -$13.7억 | -$12.9억 | -$12.8억 | |
| 주주지분 | $294억 | $165억 | $170억 | $171억 | $163억 | $174억 | $174억 | $186억 | $185억 | $201억 | $223억 | $234억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $415억 | $574억 | $540억 | $514억 | $512억 | $512억 | $509억 | $510억 | $471억 | $464억 | $431억 | $448억 | |
| 순차입금(차입금 - 현금) | $300억 | $481억 | $477억 | $435억 | $409억 | $404억 | $383억 | $353억 | $369억 | $369억 | $344억 | $352억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $42.4억 | $54.2억 | $69.1억 | $123억 | $145억 | $140억 | $91.2억 | $115억 | $103억 | $102억 | |
| 단기투자 | $21.1억 | $13.9억 | $18.5억 | $30.5억 | $19억 | $32.4억 | $1.3억 | $8.16억 | $5.13억 | $4.64억 | |
| 매출채권 | $55.4억 | $63억 | $57.5억 | $76.9억 | $106억 | $125억 | $139억 | $153억 | $144억 | $145억 | |
| 재고자산 | $12.4억 | $11.7억 | $12억 | $42.9억 | $20.7억 | $21억 | $23.4억 | $26.6억 | $25.6억 | $26.9억 | |
| 기타 유동자산 | $0 | $0 | $8.99억 | $12.3억 | -$6.85억 | $14.3억 | $17.4억 | $15.6억 | $19.4억 | $15억 | |
| 유동자산 | $137억 | $149억 | $177억 | $294억 | $302억 | $333억 | $273억 | $318억 | $298억 | $294억 | |
| 유형자산(순액) | $49.8억 | $50억 | $50.3억 | $69.6억 | $67.5억 | $69.7억 | $74.8억 | $80.4억 | $83.6억 | $91.3억 | |
| 장기투자 | $27.2억 | $24.8억 | $17.8억 | $41.7억 | $45.1억 | $27.1억 | $21.9억 | $25억 | $25.1억 | $25.1억 | |
| 영업권 | $68.8억 | $68.6억 | $65.4억 | $225억 | $205억 | $205억 | $211억 | $212억 | $217억 | $218억 | |
| 무형자산 | $13.9억 | $12.1억 | $10.9억 | $640억 | $534억 | $428억 | $364억 | $275억 | $236억 | $191억 | |
| 이연법인세자산 | $30억 | $16.1억 | $8.15억 | $5.1억 | $11.6억 | $14.4억 | $13.4억 | $27.7억 | $42.4억 | $53.8억 | |
| 기타 비유동자산 | $10.5억 | $15.3억 | $20.2억 | $25억 | $18.8억 | $16.6억 | $10.4억 | $14.3억 | $23.6억 | $27.8억 | |
| 비유동자산 | $200억 | $187억 | $173억 | $1010억 | $883억 | $761억 | $695억 | $634억 | $628억 | $606억 | |
| 자산총계 | $337억 | $336억 | $350억 | $1300억 | $1180억 | $1090억 | $968억 | $952억 | $926억 | $900억 | |
| 부채 | |||||||||||
| 매입채무 | $16.6억 | $22.5억 | $18.9억 | $24.5억 | $27.1억 | $29.5억 | $30.4억 | $32.6억 | $36억 | $35.8억 | |
| 미지급비용 | $37.5억 | $44.5억 | $6900만 | $4.93억 | $4.34억 | $3.78억 | $3.21억 | $3.49억 | $5.72억 | $4.84억 | |
| 단기차입금 | $9.92억 | $9.87억 | $17억 | $33.5억 | $23.4억 | $49.5억 | $42.6억 | $31.2억 | $20.5억 | $22.6억 | |
| 미지급세금 | $1.52억 | $2.31억 | $3.98억 | $15.2억 | $6.47억 | $7.54억 | $9.42억 | $13.7억 | $15.1억 | $9.79억 | |
| 이연수익 | $7.62억 | $8300만 | $1.72억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 기타 유동부채 | $8.62억 | $9.09억 | $57.5억 | $93.5억 | $117억 | $115억 | $120억 | $128억 | $146억 | $146억 | |
| 유동부채 | $88.4억 | $95.6억 | $107억 | $183억 | $191억 | $219억 | $219억 | $223억 | $238억 | $234억 | |
| 장기차입금 | $57.2억 | $69.8억 | $56.5억 | $434억 | $483억 | $396억 | $351억 | $367억 | $476억 | $429억 | |
| 리스부채(비유동) | $0 | $0 | $0 | $6.72억 | $8.33억 | $8.74억 | $12.6억 | $15.3억 | $13.7억 | $18.3억 | |
| 이연수익(비유동) | $5.47억 | $4.54억 | $4.68억 | $4.24억 | $3.57억 | $3.26억 | $2.83억 | $3억 | $2.3억 | $1.69억 | |
| 이연법인세부채 | $0 | $0 | $1900만 | $64.5억 | $54.1억 | $45억 | $21.7억 | $3.38억 | $3.69억 | $2.22억 | |
| 기타 비유동부채 | $22.6억 | $47.1억 | $40.7억 | $90.1억 | $65.9억 | $61.3억 | $50.5억 | $45.9억 | $28.7억 | $30.5억 | |
| 비유동부채 | $85.2억 | $121억 | $102억 | $599억 | $615억 | $514억 | $438억 | $434억 | $524억 | $481억 | |
| 부채총계 | $174억 | $217억 | $209억 | $782억 | $806억 | $733억 | $657억 | $657억 | $762억 | $715억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $2.21억 | $2.21억 | $2.21억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | $2.92억 | |
| 이익잉여금 | $335억 | $312억 | $341억 | $345억 | $213억 | $238억 | $255억 | $288억 | $149억 | $169억 | |
| 기타포괄손익누계액 | -$25억 | -$22.9억 | -$27.6억 | -$15.2억 | -$18.4억 | -$12.7억 | -$12.8억 | -$15.5억 | -$12.4억 | -$15.2억 | |
| 주주지분 | $162억 | $117억 | $140억 | $516억 | $378억 | $359억 | $311억 | $294억 | $163억 | $185억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $67.1억 | $79.6억 | $73.5억 | $475억 | $517억 | $456억 | $407억 | $415억 | $512억 | $471억 | |
| 순차입금(차입금 - 현금) | $24.7억 | $25.4억 | $4.38억 | $352억 | $371억 | $316억 | $316억 | $300억 | $409억 | $369억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
데이터 기준일 2026-11-01